Seroprevalence of primary health care workers in Saint-Petersburg during a measles epidemic

The measles situation is still unstable — there are imported cases, the formation of nosocomial foci with the involvement of medical personnel, patients and visitors of medical institutions.

Objective of the study: to assess the level of seroprevalence of primary health care workers in St. Petersburg during the period of epidemic trouble with measles.

Materials and methods: An open retrospective randomized uncontrolled study of the intensity of specific immunity to measles in 980 employees aged 18 to 78 years, examined in July-September 2018, was carried out. The level of anti-measles IgG antibodies was determined by the method of enzyme-linked immunosorbent assay (810 people) and passive hemagglutination reactions (170 people). The results are presented with the indication of the shares (%) and the calculation of the 95% confidence interval according to Clopper — Pearson. Differences between groups were assessed using Pearson's chi-square test (%2). Differences in the groups were considered statistically significant when the criterion level was p < 0.05.

Results: It was found that 8.2% of personnel are not protected against measles infection. At the same time, the number of seronegative persons among doctors (8.1 %), nurses (7.7%) and non-medical workers (9.6%) differed statistically. Age-related differences in the immune layer were revealed — the greatest susceptibility was observed in persons under 30 years of age (1 8.3%). Anti-measles antibodies in those who had been ill persisted for a long time and at a high level. At the same time, the intensity of post-vaccination immunity decreased over time, and 20 years after immunization, the number of seronegative individuals increased significantly. Only 64.1 % of those surveyed had two vaccinations, more than a third were immunized once. Nevertheless, the proportion of people unprotected from measles exceeded the criterion of epidemic well-being with the same frequency in both groups (9.2% and 1 0.4%, respectively).

The results of a serological study showed that the presence of a record of two vaccinations in the certificate in 9.2% of cases does not guarantee protection in case of contact with a patient with measles. Only a serological examination is evidence of specific immunity to measles infection.

1. Griffin DE. Measles, in Fields Virology. Wolters Kluwer/Lippincott, Williams & Wilkins, Philadelphia, 2013:1042—1069.

2. Schneider-Schaulies, J., Niewiesk S., Schneider-Schaulies S., ter Meulen V. Measles virus in the CNS: the role of viral and host factors for the establishment and maintenance of a persistent infection. J. Neurovirol. 1999; 5: 61 3—622. doi: 10.3109/13550289909021290

3. Ayata M, Hisashi O. Subacute sclerosing panencephalitis (SSPE): viral mutation and neuropathogenicity. Virus. 2003; 53(1):15—23. doi:10.2222/jsv.53.15

4. Holzmann Н., Idengel Н., Tenbusch М., Doerr H.W Eradication of measles: remaining challenges. Medical Microbiology and Immunology. 2016; 205:201—208. doi: 10.1 007/s00430-016-0451-4

5. Fifth Meeting of the European Regional Verification Commission for Measles and Rubella Elimination (RVC) 24—26 October 2016. WHO Regional Office for Europe. 2017: 73.

6. Program «Elimination of measles and rubella in the Russian Federation» (2016—2020). (In Russ.).

7. Carrillo-Santisteve P., Lopalco P.L. Measles still spreads in Europe: who is responsible for the failure to vaccinate? Clin. Microbiol. Infect. 2012; 18(5):50—56. https://doi.org/10.1111/j.1469-0691.2012.03982.x

8. On the state of sanitary and epidemiological well-being of the population in the Russian Federation in 2018: State report. Moscow: Federal Service for Supervision of Consumer Rights Protection and Human Welfare, 2019: 254. (In Russ.)

9. Chernova T.M., Timchenko V.N., Pavlova E.B., Barakina E.V. Congenital rubella and measles in a period of global eradication. Pediatric. 2019; 98(3): 172-179. (In Russ.). doi: 10.24110/0031-403X-2019-98-3-172-179

10. Resolution of the Chief State Sanitary Doctor in St. Petersburg dated June 19, 2018 No. 5 «On strengthening measles prevention measures in St. Petersburg» (as amended on July 4, 201 8). (In Russ.).

11. J. Trmal, J Kupcova, L Dvorakova, D Vaculikova, R Limberkova, I Slajova, J Pospisilova. Measles re-emerging in the Usti Region. Epidemiol Mikrobiol Imunol. 2014 Jun; 63(2):154-9.

12. Williams WW, Preblud SR, Reichelderfer PS, Hadler SC. Vaccines of importance in the hospital setting. Problems and developments. Infect Dis Clin North Am. 1989; 3(4):701-22.

13. Hahne SJ, Nic Lochlainn LM, van Burgel ND, Kerkhof J, Sane J, Yap KB, van Binnendijk RS. Measles Outbreak Among Previously Immunized Healthcare Workers, the Netherlands, 2014. J Infect Dis. 2016; 214(12): 1980-1986. doi: 10.1093/infdis/jiw480

14. Botelho-Nevers E., Cassir N., Minodier P., LaporteR., Gautret P., Ba-diaga S., Thiberville DJ, Ninove L., Charrel R., Brouqui P. Measles among healthcare workers: a potential for nosocomial outbreaks. Euro Surveill. 2011; 16(2): 19764.

15. Methodical instructions «MU 3.1.2943-11 Organization and carrying out of serological monitoring of the state of collective immunity to infections controlled by means of specific prevention (diphtheria, tetanus, whooping cough, measles, rubella, mumps, poliomyelitis, hepatitis B)». (In Russ.).

16. Medunitsin N.V. Correction of the development of immunity during vaccination. Biopreparaty, Profilaktika, Diagnostika, Lechenie = Biologicals, Prevention, Diagnostics, Treatment. 2010; 1(37):18-24. (In Russ.).

17. Order of the Ministry of Health of the USSR No. 426 «On measures to improve the prevention of measles» (1986). (In Russ.).

18. Order of the Ministry of Health of the Russian Federation of December 18, 1997 N 375 «On the vaccination schedule of preventive vaccinations». (In Russ.).

19. Kumakura S., Shibata H., Onoda K., Nishimura N., Matsuda C., Hirose M. Seroprevalence survey on measles, mumps, rubella and varicella antibodies in healthcare workers in Japan: sex, age, occupational-related differences and vaccine efficacy. Epidemiol Infect. 2014; 142(1 ):1 2-1 9. doi: 10.1017/S0950268813000393

20. Holka J., Pawlak K., Ciepiela O. Seroprevalence of IgG antibodies against measles in a selected Polish population - do we need to be re-vaccinated? Central-european Journal of Immunology. 2019; 44(4):380-383. doi: 10.5114/ceji.2019.92789

21. Smetana J., Chlibek R., Hanovcova I., Sosovickova R., Smetanova L., Gal P., Dite P. Decreasing Seroprevalence of Measles Antibodies after Vaccination - Possible Gap in Measles Protection in Adults in the Czech Republic. Plos One. January 13, 2017. https:// doi.org/10.1 371/journal.pone.0170257

22. Department of Health. Managing Measles Exposures in Health Care Workers. Available from: https://www.health.state.mn.us/diseases/measles/hcp/control.html